Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2V617F in granulocytes

被引:49
作者
Lasho, TL [1 ]
Mesa, R
Gilliland, DG
Tefferi, A
机构
[1] Mayo Clin Rochester, Rochester, MN USA
[2] Mayo Clin Coll Med, Rochester, MN USA
[3] Harvard Univ, Sch Med, Boston, MA USA
关键词
myeloproliferative disorder; mutation analysis; clonality;
D O I
10.1111/j.1365-2141.2005.05682.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:797 / 799
页数:3
相关论文
共 6 条
  • [1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    Baxter, EJ
    Scott, LM
    Campbell, PJ
    East, C
    Fourouclas, N
    Swanton, S
    Vassiliou, GS
    Bench, AJ
    Boyd, EM
    Curtin, N
    Scott, MA
    Erber, WN
    Green, AR
    [J]. LANCET, 2005, 365 (9464) : 1054 - 1061
  • [2] JAMES C, 2005, IN PRESS NATURE
  • [3] A gain-of-function mutation of JAK2 in myeloproliferative disorders
    Kralovics, R
    Passamonti, F
    Buser, AS
    Teo, S
    Tiedt, R
    Passweg, JR
    Tichelli, A
    Cazzola, M
    Skoda, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) : 1779 - 1790
  • [4] Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia
    Reeder, TL
    Bailey, RJ
    Dewald, GW
    Tefferi, A
    [J]. BLOOD, 2003, 101 (05) : 1981 - 1983
  • [5] Steensma DP, 2005, BLOOD
  • [6] TEFFRI A, 2005, IN PRESS CELL CYCLE